8-K: ZSPACE Secures $3M in Private Placement, Issues High-Dividend Preferred Stock

ZSPACE, Inc. has raised $3 million through a private placement of Series P Convertible Preferred Stock and warrants, with potential for an additional $7 million.

Summary

• ZSPACE, Inc. entered into a Securities Purchase Agreement (SPA) with an institutional investor on January 23, 2026.
• The company issued and sold 1,500,000 shares of Series P Preferred Stock and warrants to purchase 1,000,000 shares of common stock for an aggregate purchase price of $3,000,000 at an initial closing on January 27, 2026.
• The Series P Preferred Stock has a stated value of $2.00 per share and carries a cumulative dividend of 18% per annum, payable annually in additional shares of Series P Preferred Stock.
• The warrants have an initial exercise price of $3.00 per share and a five-year term.
• The SPA allows for additional closings within one year, up to a total of $10,000,000 in aggregate purchases.
• The Series P Preferred Stock includes significant protective provisions, requiring majority holder approval for actions like altering rights or creating senior stock.
• Automatic conversion of Series P Preferred Stock occurs on the fifth anniversary of the issue date at the lower of the conversion price or 80% of the 90-day VWAP of common stock.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a highly negative development for common shareholders due to the extremely high cost of capital (18% cumulative dividend), significant dilution potential from the preferred stock and warrants, and the restrictive control provisions granted to the institutional investor.

Positives

• Secured $3,000,000 in immediate funding from an institutional investor.
• Potential to raise an additional $7,000,000 through subsequent closings within one year.
• The capital infusion provides liquidity and supports ongoing operations.

Negatives

• The Series P Preferred Stock carries a very high cumulative dividend rate of 18% per annum, payable in kind, which will significantly increase the preferred stock outstanding over time.
• The automatic conversion feature on the fifth anniversary at 80% of the 90-Day VWAP could lead to substantial dilution for existing common shareholders if the stock price declines.
• Preferred shareholders have significant protective voting rights, potentially limiting the company's flexibility in future corporate actions.
• The warrants to purchase 1,000,000 shares of common stock at $3.00 per share represent additional potential dilution.
• An Event of Default triggers immediate redemption of all outstanding Preferred Stock with an 18% per annum dividend, posing a significant financial risk.

Risks

• Significant Dilution: The issuance of Series P Preferred Stock with an 18% cumulative dividend payable in kind, coupled with warrants and an automatic conversion feature at 80% of VWAP, poses a substantial risk of future dilution for common shareholders.
• High Cost of Capital: The 18% annual dividend rate on the preferred stock is a very high cost of capital, indicating potential financial distress or a challenging funding environment.
• Loss of Control: The protective provisions granted to Series P Preferred Stock holders, requiring their affirmative vote for certain corporate actions, could limit the company's strategic flexibility and management's control.
• Market Price Volatility: The conversion terms tied to the 90-Day VWAP expose common shareholders to further dilution if the stock price underperforms.
• Event of Default: Specific events, such as sustained stock suspension or delisting, or failure to meet reporting requirements, trigger immediate redemption of preferred stock at an accelerated dividend rate, which could lead to severe financial strain or bankruptcy.
• Future Capital Needs: While $3 million was raised, the potential for an additional $7 million suggests ongoing capital needs, and the terms of future tranches could be similarly dilutive.

Future Outlook

The company has secured initial funding and has the option to raise an additional $7 million within one year through subsequent closings under similar terms. The Series P Preferred Stock will become convertible at the holder's option starting on the third anniversary of its issuance and will automatically convert into common stock on the fifth anniversary, with the conversion rate potentially tied to 80% of the 90-day VWAP, which could lead to significant future dilution.

Industry Context

StockSavvy.ai notes that securing capital through convertible preferred stock and warrants, especially with an 18% cumulative dividend, often signals a challenging funding environment or a company in need of immediate liquidity. While the $3 million infusion provides short-term relief, the highly dilutive and restrictive terms suggest the company may have limited alternative financing options. This type of financing can be particularly attractive to institutional investors seeking high yields and significant downside protection, but it places a substantial burden on existing common shareholders.

Comparison to Industry Standards

• The 18% cumulative annual dividend rate on the Series P Preferred Stock is significantly higher than typical preferred stock dividend rates for established, financially stable companies, which often range from 4-8%. This high rate is more commonly seen in distressed companies or those with limited access to traditional capital markets.
• The automatic conversion feature at 80% of the 90-Day VWAP on the fifth anniversary is a highly dilutive mechanism, often referred to as a "death spiral" or "toxic" financing, as it incentivizes the investor to drive down the common stock price to maximize their conversion shares. This contrasts sharply with standard convertible notes or preferred stock that typically convert at a fixed premium to the common stock price or a fixed conversion ratio.
• The protective provisions granting preferred shareholders a majority vote on key corporate actions (e.g., altering rights, creating senior stock) are common in venture capital or distressed debt financings but are more extensive than typical for publicly traded companies, indicating a significant shift in control to the institutional investor.
• The warrant exercise price of $3.00, compared to the preferred stock purchase price of $2.00, provides an additional equity upside for the investor, which is standard in such structured financings but adds to the overall dilutive impact.

Corporate Governance

Stakeholder Impact

• Shareholders (Common): Significant potential for dilution from the conversion of Series P Preferred Stock (especially with the 80% VWAP clause) and the exercise of warrants. Their voting power may also be diminished due to the preferred stock's protective rights.
• Company: Gains immediate capital ($3 million, with potential for $7 million more) to fund operations, but at a very high cost of capital (18% cumulative dividend) and with increased governance restrictions.
• Institutional Investor (Purchaser): Acquires a high-yield, protected investment with significant upside potential through warrants and a favorable conversion mechanism, along with substantial influence over corporate decisions.

Next Steps

• Potential for additional closings under the Securities Purchase Agreement within one year, up to an aggregate of $10,000,000.
• Holders of Series P Preferred Stock may opt to convert their shares into Common Stock starting on the third anniversary of the Original Issue Date.
• All outstanding Series P Preferred Stock will automatically convert into Common Stock on the fifth anniversary of the Original Issue Date.
• The company must reserve sufficient common stock for conversion and comply with Trading Market rules regarding share issuance.

Key Dates

Recommendation

The terms of this private placement, particularly the 18% cumulative dividend on the Series P Preferred Stock and the highly dilutive automatic conversion feature (80% of 90-Day VWAP), are exceptionally unfavorable for existing common shareholders. These terms suggest a company in a precarious financial position, forced to accept 'toxic' financing. The significant protective provisions granted to the institutional investor also indicate a substantial loss of control for common shareholders. This transaction is highly dilutive, expensive, and signals severe underlying financial weakness, warranting a strong sell recommendation for common stock.

Keywords

ZSPACE, ZSPC, SEC Filing, 8-K, Private Placement, Preferred Stock, Warrants, Capital Raise, Dilution, Convertible Securities, Corporate Governance, Institutional Investor, Securities Purchase Agreement, Equity Financing